Hypoglycaemia has long been recognised as a feature of the failure of metabolic adaptation in infants who are small for gestational age (SGA). This study examined the process of metabolic adaptation by measuring, longitudinally, the concentrations of metabolic fuels and substrates in 33 SGA infants in the first postnatal week, and relating these to cross sectional data in 218 infants of appropriate weight for gestational age (AGA).
although there were no differences in blood glucose concentrations, SGA term infants had lower mean ketone body concentrations (for example day 2: 0 07 v 0-41 mmol/1), and failed to mount a ketogenic response to low blood glucose concentrations. At birth, SGA preterm infants had lower mean blood glucose concentrations than AGA preterm infants (3.17 v 4*16 mmol/1), but there were few postnatal metabolic differences between the two groups. Mean blood glucose concentrations did not differ between AGA and SGA preterm infants. For variables that differed between the groups, multiple regression analysis suggested that both the degree and asymmetry of growth retardation were related to the severity of the metabolic abnormalities.
These data suggest that, although there are early metabolic differences between SGA and AGA infants, it is possible that current clinical management is effective in preventing subsequent hypoglycaemia. This is important because of the failure of SGA infants to mount a ketogenic response.
It has long been known that small for gestation age (SGA) infants are less able to achieve the metabolic adaptation required of them at birth and are at risk of hypoglycaemia.' 2 It appears that the degree of growth retardation and relative body proportions of the infant affect vulnerability.3-5 Hyperglycaemia has also been described in SGA infants. 6 It is now known that some metabolic effects of intrauterine growth retardation may be evident antenatally, such as by hypoxia, acidosis, hyperlactataemia, and hypoglycaemia. [7] [8] [9] [10] The postnatal metabolic problems of SGA infants have been reviewed by Usher,1' Mestyan,'2 Jones and Roberton,13 and Hay,14 who suggested that the increased risk of hypoglycaemia may be secondary to increased glucose utilisation (partly because of the disproportionately high brain weight), hormonal or enzymatic imbalance resulting in failure of gluconeogenesis, reduced stores of fat and glycogen, and inability to mobilise fat stores and oxidise fatty acids to ketone bodies.
These studies of postnatal metabolic events were performed at a time when intravenous and enteral feeding policies were less liberal than at present. The adequate provision of enteral and parenteral energy may counteract the metabolic difficulties of SGA infants so that hypoglycaemia is not seen.
The purpose of the present study was to investigate whether SGA infants exhibited any differences in metabolic adaptation compared with infants who were of appropriate weight for gestational age (AGA) when exposed to present feeding policies (which encourage early and frequent milk feeds and intravenous glucose supplementation if adequate enteral feed volumes are not tolerated). We compared the metabolic changes seen after birth in a group of healthy AGA infants and a group of SGA infants to investigate whether failure of metabolic adaptation was seen in the SGA group, first, at birth, and second, after the commencement of enteral and intravenous feeding, and whether hypoglycaemia was the only biochemical evidence of failure of metabolic adaptation.
Subjects and methods
Thirty three singleton infants, of mixed gestational age, who were suspected antenatally of being SGA, and who had birth weights below the 10th centile, were studied longitudinally. Prefeed blood samples were taken once a day for the first postnatal week (SGA infants Significantly more preterm SGA infants than preterm AGA infants were born by caesarean section, reflecting a high degree of obstetric concern.
For all infants, there were significantly lower mean birth weight SD and MAC:HC SD scores for infants of smoking mothers than for infants whose mothers did not smoke (-034 v 0O08, p<0 05; 0-52 v 110, p<005).
In the first few postnatal days, term SGA infants received more frequent feeds, and higher intakes of milk, intravenous glucose and energy than AGA infants, reflecting the feed and fluid regimens presently in use for such babies. On day 2, preterm SGA infants had higher intravenous glucose intakes than preterm AGA infants, and on day 5, SGA babies had higher milk intakes than AGA babies. These differences are shown in table 3.
Significant differences between the groups, in terms of blood metabolite concentrations are shown in table 4. Figure 2 demonstrates (fig 3) . However Enteral feed (ml/kg/day) Figure 6 Relationship between ketone body concentration and enteralfeed volume in preterm AGA and SGA infants on the second postnatal day. evidence that SGA infants had undergone some perinatal stress: term SGA infants had higher cord blood concentrations of nonesterified fatty acid and lactate, and these high levels persisted in the first six postnatal hours (see below). Although these infants mounted a poor ketogenic response to hypoglycaemia after the first postnatal day, the fact that, as for AGA infants, there was a positive relationship between glucose and ketone body concentrations on the first postnatal day suggests that SGA infants demonstrated an appropriate metabolic response to the stress of delivery. The finding on multiple regression analysis of the relationship between the degree of growth retardation and raised nonesterified fatty acids, total gluconeogenic substrate, and lactate concentrations provides further evidence of antenatal stress in growth retarded fetuses. In contrast, the finding of low cord glucose concentrations in SGA preterm infants, which were correlated with the degree of growth retardation, is in accordance with the work of Soothill et al3' Smith et al,9 and Economides and Nicolaides,'0 and suggests that, for preterm infants in this study, intrauterine growth retardation was contributing to metabolic stress in utero.
The finding that infants with clinical evidence of fetal distress did not have significantly lower cord pH values than infants without fetal distress, but had significantly higher cord blood lactate concentrations, suggests that blood lactate may be a more sensitive marker for fetal distress than cord pH. This calls into question the results of studies which suggest that the principal risk factor for adverse neonatal outcome is cord pH.20
The differences found between enteral and intravenous intakes for term SGA and AGA infants probably reflected the additional clinical and nursing attention the former received. In contrast, the lack of differences between preterm AGA and SGA infants may be the result of the close attention paid to the nutrition of all preterm babies, irrespective of their relative size, with uniform policies of early enteral feeding.
There was evidence that the feeding regimens used were effective in maintaining adequate blood glucose concentrations in the SGA infants studied. On each day, the mean blood glucose concentrations were not significantly different for SGA and normal infants. This is in accord with a recent study by Previous studies have examined the ability of the MAC:HC ratio to predict metabolic abnormalities in SGA infants.5 However, there are no data regarding the effects of both body size and asymmetry of growth retardation of fuels other than glucose. In the present study, the multiple regression analysis findings indicate that both degree of growth retardation, as measured by birthweight SD score, and asymmetry of growth retardation, as measured by MAC:HC, separately affected aspects of postnatal metabolic adaptation. The degree of growth retardation, at term, was the most important determinant of relatively high non-esterified fatty acid concentrations at birth and low ketone body concentrations on the third postnatal day. The more asymmetrical babies, at term, had higher total gluconeogenic substrate at birth and lower nonesterified fatty acids on the third postnatal day. The effects of clinical management in the form of provision of energy, however, overrode these factors on the second postnatal day. For preterm babies, more severe growth retardation was associated with lower cord blood glucose concentrations. We did not find the MAC:HC ratio correlated with blood glucose concentrations at birth, or during the early postnatal period, and suggest that to consider only the effect of brain:body size on glucose concentrations is too simplistic.
This study has demonstrated that changes in blood glucose concentrations provide an inadequate description of the process of metabolic adaptation in SGA infants.
The patterns of metabolic adaptation seen in SGA term infants, with failure of ketogenesis and accumulation of gluconeogenic precursors, were similar to, but more prolonged than those seen in healthy preterm infants; SGA and AGA preterm infants were found to have few significant differences in terms of metabolic adaptation. The process by which preterm and SGA babies eventually acquire mature metabolic responses, and the long term clinical implications of these metabolic differences will only be found by case-control follow up studies. In addition, the role of enteral feeding, and of dietary components such as carnitine, warrant further study.
The failure to utilise gluconeogenic precursors and the failure of ketogenesis are reminders that these SGA infants, especially when very wasted, were unable to respond to low blood glucose concentrations, and these deficiencies persisted for almost all of the first postnatal week. Attention to early enteral and intravenous nutrition of these infants resulted in maintenance of normoglycaemia for the majority of infants. Efforts must continue to prevent severe intrauterine growth retardation and to seek effective means of promoting metabolic adaptation in these infants once they are born. We thank the parents who gave consent for the inclusion of their babies in the study and acknowledge the assistance of Ms A McGann with metabolite assays.
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